2 news items
Positive One-Year Data from Phase 2 Study of Pegcetacoplan in Post-Transplant Recurrence of C3G and IC-MPGN Presented as Late-Breaker at ERA Congress
APLS
24 May 24
. Providing reliable access to innovative medicines in the areas of haematology, immunology, and specialty care, Sobi has approximately 1,800 employees
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
APLS
4 Apr 24
. (NASDAQ:APLS) today announced that the company approved the grant of equity awards to one new employee
- Prev
- 1
- Next